SCHEMBL4934920

SCHEMBL4934920

CC(C)(C)OC(=O)NC(CCc1nc2ccccc2n1Cc1ccc(C(C)(C)C)cc1)C(=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
POLB P06746 2/20 0.52
AGTR1 P30556 3/20 0.44
AGTR2 P50052 3/20 0.44
MAPT P10636 1/20 0.43
GNRHR P30968 1/20 0.43
TBXA2R P21731 3/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
CYP3A4 P08684 1/20 0.43
SCN9A Q15858 1/20 0.43
SCN10A Q9Y5Y9 1/20 0.43
DRD2 P14416 1/20 0.43
PPARG P37231 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4934913 1.00 TP53 (0.52) TP53SMN1; SMN2POLBAGTR1AGTR2
SCHEMBL4934094 0.93 TP53 (0.55) TP53SMN1; SMN2POLBAGTR1AGTR2
SCHEMBL4934103 0.93 TP53 (0.55) TP53SMN1; SMN2POLBAGTR1AGTR2
SCHEMBL4933601 0.91 TP53 (0.54) TP53SMN1; SMN2POLBAGTR1AGTR2
SCHEMBL4933609 0.91 TP53 (0.54) TP53SMN1; SMN2POLBAGTR1AGTR2
SCHEMBL4934802 0.91 GNRHR (0.43) TP53SMN1; SMN2POLBGNRHRCYP3A4
SCHEMBL5732545 0.87 GNRHR (0.42) POLBAGTR1AGTR2MAPTGNRHR
SCHEMBL5732549 0.87 GNRHR (0.42) POLBAGTR1AGTR2MAPTGNRHR
SCHEMBL4935274 0.86 MEN1 (0.47) POLBMAPT
SCHEMBL4935261 0.86 MEN1 (0.47) POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 TP53 2597/4885SMN1; SMN2 3068/4885POLB 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.